Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2012
10/24/2012CN102743532A Chinese medicine for preventing and treating cerebral infarction
10/24/2012CN102743529A Traditional Chinese medicinal preparation for treating apoplexy and preparation process thereof
10/24/2012CN102743528A Traditional Chinese medicinal preparation for treating apoplexy and preparation process thereof
10/24/2012CN102743527A Traditional Chinese medicinal preparation for treating apoplexy and preparation process thereof
10/24/2012CN102743505A Health care fluid for alleviating vasotonia
10/24/2012CN102743482A Traditional Chinese medicine for preventing postpartum pulmonary embolism
10/24/2012CN102743428A Applications of dalbergia odorifera t.chen leaves and preparation method for extract of the same
10/24/2012CN102743418A Seabuckthorn fruit oil powder and preparation method thereof
10/24/2012CN102743406A Chinese medicine active component composition capable of relaxing blood vessels
10/24/2012CN102743386A Tetramethylpyrazine and borneol dropping pill for treating ardiovascular and cerebrovascular diseases and preparation method for dropping pill
10/24/2012CN102743381A Stable candesartan cilexetil amlodipine pharmaceutical composition and its preparation method
10/24/2012CN102743374A Application of bellidifolin in preparation of drugs for prevention and treatment of cardiacarrhythmia
10/24/2012CN102743371A Medicine for treating retinal neovascular diseases
10/24/2012CN102743368A Compounds for the treatment of metabolic disorders
10/24/2012CN102743361A Irbesartan hydrochlorothiazide capsule
10/24/2012CN102743352A Triamcinolone tablet and polymorphs and preparation method
10/24/2012CN102743350A Methionine-vitamin B1 composition injection
10/24/2012CN102743349A Small-volume puerarin freeze-dried powder injection and its preparation method and production device
10/24/2012CN102743340A Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/24/2012CN102742971A Shoe pad capable of preventing and curing hypertension
10/24/2012CN102742843A Health-care functional food for preventing hemorrhoid
10/24/2012CN102742691A Health-care tea drink with blood pressure lowering effect and preparation method thereof
10/24/2012CN102335240B Chinese medicinal composition for treating hemorrhagic stroke as well as preparation method and application thereof
10/24/2012CN102274357B Pharmaceutical composition for treating coronary arteriosclerotic heart disease and preparation method thereof
10/24/2012CN102274223B Compound preparation containing telmisartan and amlodipine
10/24/2012CN102266495B Medicament for treating hypertension and preparation method thereof
10/24/2012CN102266308B Method for preparing odor masking sustained-release garlicin composite micro-capsules
10/24/2012CN102266307B Valsartan capsules and preparation method thereof
10/24/2012CN102093380B Cyclic icaritin aglycon as well as preparation method and application of cyclic icaritin aglycon
10/24/2012CN102068657B Quality control method of venation relaxing pill as Chinese herbal preparation
10/24/2012CN102000177B Medicine for treating haemorrhoids
10/24/2012CN101966261B Medicament for treating high blood pressure and preparation method thereof
10/24/2012CN101957346B Novel method for studying medicament metabolism by using model organism zebrafish
10/24/2012CN101904875B Ganoderma tsugae active substance, preparation method thereof and composition thereof
10/24/2012CN101815702B Novel crystalline form
10/24/2012CN101801416B Sealmess capsule
10/24/2012CN101766690B Multipurpose utilization method for improving the value of schisandra chinensis medicinal material
10/24/2012CN101744852B Preparation method of acanthopanax effervescent tablet and products thereof
10/24/2012CN101607954B Danshensu derivative, preparation method thereof, and application thereof in pharmacy
10/24/2012CN101607897B (Z)-2-acetyloxy-3-(3,4-dihydroxylbenzenyl) acrylic acid and synthesis method and application thereof
10/24/2012CN101374844B Pyrrolopyridazinone compound
10/23/2012US8293902 Quinazoline compounds
10/23/2012US8293755 Treatment of statin side effects using uridine derivatives
10/23/2012US8293723 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
10/23/2012US8293713 Beta-turn peptidomimetic cyclic compounds for treating dry eye
10/23/2012US8293703 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/23/2012US8293273 Controlled release and taste masking oral pharmaceutical composition
10/23/2012US8293223 Treatment of organ injuries and burns using placental stem cells
10/23/2012CA2689659C Nitrogen-containing heterocyclic derivative having 11.beta.-hydroxysteroid dehydrogenase type 1 inhibitory activity
10/23/2012CA2654661C Compositions comprising modified lcat and use thereof for treating atherosclerosis
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/23/2012CA2412494C Agonist anti-trk-c monoclonal antibodies
10/18/2012WO2012142308A1 Prodrugs of inhibitors of plasma kallikrein
10/18/2012WO2012141487A2 Cycloalkenyl aryl derivatives for cetp inhibitor
10/18/2012WO2012141385A1 Antihypertensive pharmaceutical composition
10/18/2012WO2012141280A1 Dna vaccine
10/18/2012WO2012140894A1 Pharmaceutical composition
10/18/2012WO2012140327A1 Method for determining the risk of cardiovascular events using igfbp fragments
10/18/2012WO2012140020A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012139888A1 Branched 3-phenylpropionic acid derivatives and the use thereof
10/18/2012WO2012139736A1 Pharmaceutical composition comprising bosentan
10/18/2012WO2012139524A1 Cb1 receptor inhibitor with low toxicity and optical activity and preparation method and use thereof
10/18/2012WO2012139495A1 Mineralocorticoid receptor antagonists
10/18/2012WO2012139227A1 Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction
10/18/2012WO2012122334A3 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
10/18/2012WO2012108990A3 Peptide-phospholipid conjugates
10/18/2012WO2012102555A3 Fucoidan for thrombolysis, derived from seaweed
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264826 N-Acetyl Beta Alanine Methods of Use
10/18/2012US20120264816 Sulfated Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Proliferation
10/18/2012US20120264812 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
10/18/2012US20120264801 5-membered heterocycle-based p38 kinase inhibitors
10/18/2012US20120264799 Indane-amine derivatives, their preparation and use as medicaments
10/18/2012US20120264798 Prodrugs of inhibitors of plasma kallikrein
10/18/2012US20120264797 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/18/2012US20120264791 Fatty acid niacin conjugates and their uses
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264777 Oxadiazole beta carboline derivatives as antidiabetic compounds
10/18/2012US20120264773 Organic compounds
10/18/2012US20120264772 Antihypertensive pharmaceutical composition
10/18/2012US20120264769 Methanocarba adenosine derivatives and dendrimer conjugates thereof
10/18/2012US20120264762 Heterocyclic Compounds as CCR2 Antagonists
10/18/2012US20120264759 Benzyl substituted triazine derivatives and their therapeutical applications
10/18/2012US20120264756 Phosphatidylcholine Transfer Protein Inhibitors
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264753 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same
10/18/2012US20120264752 Dual-acting antihypertensive agents
10/18/2012US20120264749 Morpholine-spirocyclic piperidine amides as modulators of ion channels
10/18/2012US20120264747 Triazolopyridine jak inhibitor compounds and methods
10/18/2012US20120264746 Cell migration modulating compounds
10/18/2012US20120264743 Crystalline forms of (r)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1h-3-benzazepine hydrochloride
10/18/2012US20120264733 Heterocyclic compound and use thereof
10/18/2012US20120264732 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264730 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264729 Co-crystals and salts of ccr3-inhibitors
10/18/2012US20120264725 Substituted porphyrins
10/18/2012US20120264721 Analogues of cilostazol
10/18/2012US20120264718 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 1595